Economic and Disease Burden of Dengue in Mexico

• Eduardo A. Undurraga,

  Affiliation Schneider Institutes for Health Policy, Heller School, Brandeis University, Waltham, Massachusetts, United States of America

  ⨯
• Miguel Betancourt-Cravioto,

  Affiliation Carlos Slim Health Institute, Mexico City, Mexico

  ⨯
• José Ramos-Castañeda,

  Affiliations Instituto Nacional de Salud Pública, Cuernavaca, Mexico, Center for Tropical Diseases, University of Texas-Medical Branch, Galveston, Texas, United States of America

  ⨯
• Ruth Martínez-Vega,

  Affiliations Instituto Nacional de Salud Pública, Cuernavaca, Mexico, Organización Latinoamericana para el Fomento de la Investigación en Salud, Bucaramanga, Colombia

  ⨯
• Jorge Méndez-Galván,

  Affiliation Hospital Infantil de México Federico Gómez, Mexico City, Mexico

  ⨯
• Duane J. Gubler,

  Affiliation Duke-NUS Graduate Medical School, Singapore

  ⨯
• María G. Guzmán,

  Affiliation Pedro Kourí Tropical Medicine Institute, Havana, Cuba

  ⨯
• Scott B. Halstead,

  Affiliation Pediatric Dengue Vaccine Initiative, Rockville, Maryland, United States of America

  ⨯
• Eva Harris,

  Affiliation University of California, Berkeley, Berkeley, California, United States of America

  ⨯
• Pablo Kuri-Morales,

  Affiliation Ministry of Health, Mexico City, Mexico

  ⨯
• Roberto Tapia-Conyer,

  Affiliation Carlos Slim Health Institute, Mexico City, Mexico

  ⨯
• Donald S. Shepard

  * E-mail: shepard@brandeis.edu

  Affiliation Schneider Institutes for Health Policy, Heller School, Brandeis University, Waltham, Massachusetts, United States of America

  ⨯